Skip to Main Content

Paper Details

A phase I trial of oblimersen sodium in combination with cisplatin and 5-fluorouracil in patients with advanced esophageal, gastroesophageal junction, and gastric carcinoma.
Am J Clin Oncol
13
2010

Datasets

Release 1.2